. 2005 Oct 8;55(8):958–968. doi: 10.1007/s00262-005-0084-8

Table 3.

Tumor response to vaccination

No. of evaluable patients	20
Median time to progression^a (N=20)	145 days
Median time to progression^a (N=20)	95% CI=97 to 188 days
Median overall survival at the end of study^a (N=20)	583 days
Median overall survival at the end of study^a (N=20)	95% CI=291 to N/A days
No. of patients with stable disease after one cycle	11/20 (55%)
No. of patients with progression after one cycle	8/20 (40%)
No. of patients disease-free after one cycle	1/20 (5%)^b

^aMedian time to progression and median survival times were calculated by Kaplan–Meier method

^bPatient 01–013 was made disease free by surgery for 414 days